Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Daniel Keane

Pfizer to move daily weight-loss pill to clinical trials

Pfizer plans to move a version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday.

The pharmaceutical giant said it would begin studies evaluating different doses of the treatment later this year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.